Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q2 FY22 results · Jul–Sep 2021
Caplin Point Laboratories reported revenue from operations of ₹303.53 crore (up 13.2% from Q2 FY21) and net profit of ₹76.82 crore (up 22.3% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a consolidated basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 303.53 | 268.12 | +13.2% | 300.44 | +1.0% |
| Other income | 8.49 | 1.76 | +382.4% | 9.21 | −7.8% |
| Total income | 312.02 | 269.88 | +15.6% | 309.65 | +0.8% |
| Profit before tax | 97.73 | 79.83 | +22.4% | 89.52 | +9.2% |
| Net profit for the period | 76.82 | 62.83 | +22.3% | 71.53 | +7.4% |
| EPS, basic (₹) | 9.91 | 7.52 | +31.8% | 9.37 | +5.8% |
| Net margin (%) | 25.3 | 23.4 | 23.8 |
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 160.40 | 116.92 | +37.2% | 127.50 | +25.8% |
| Other income | 18.42 | 3.24 | +468.5% | 19.33 | −4.7% |
| Total income | 178.82 | 120.16 | +48.8% | 146.83 | +21.8% |
| Profit before tax | 83.49 | 53.99 | +54.6% | 69.41 | +20.3% |
| Net profit for the period | 65.16 | 41.26 | +57.9% | 54.55 | +19.5% |
| EPS, basic (₹) | 8.61 | 5.45 | +58.0% | 7.21 | +19.4% |
| Net margin (%) | 40.6 | 35.3 | 42.8 |
Consolidated
- Filed with BSE
- 03 Nov 2021, 13:51 IST
- Board meeting
- 02 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Nov 2021, 13:51 IST
- Board meeting
- 02 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE